The Oncologist

Journal

Publication Venue For

  • Venetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the US. 2022
  • Inequity in Telemedicine Use Among Patients with Cancer in the Deep South During the COVID-19 Pandemic.  27:555-564. 2022
  • Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer.  27:220-227. 2022
  • Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience.  27:144-148. 2022
  • Use of Single-Item Self-Rated Health Measure to Identify Frailty and Geriatric Assessment-Identified Impairments Among Older Adults with Cancer.  27:e45-e52. 2022
  • Homologous Recombination Deficiency: Concepts, Definitions, and Assays.  27:167-174. 2022
  • First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors.  26:925-e1918. 2021
  • Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms.  26:e2021-e2033. 2021
  • It Takes Two to Tango: Patients’ and Providers’ Perspectives in Tobacco Cessation and Head/Neck Cancer.  26:761-770. 2021
  • Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR).  26:560-e1103. 2021
  • Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance.  26:e608-e621. 2021
  • Capacity to Provide Geriatric Specialty Care for Older Adults in Community Oncology Practices.  25:1032-1038. 2020
  • Efficacy of BRAF-Inhibitor Therapy in BRAFV600E-Mutated Adult Langerhans Cell Histiocytosis.  25:1001-1004. 2020
  • Phase I Study of Ramucirumab Plus Merestinib in Previously Treated Metastatic Colorectal Cancer: Safety, Preliminary Efficacy, and Pharmacokinetic Findings.  25:e1628-e1639. 2020
  • Designing an Effective Colorectal Cancer Screening Program in Egypt: A Qualitative Study of Perceptions of Egyptian Primary Care Physicians and Specialists.  25:e1525-e1531. 2020
  • Sustained Carbohydrate Antigen 19-9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival.  25:859-866. 2020
  • Bioelectrical Impedance Analysis for the Assessment of Sarcopenia in Patients with Cancer: A Systematic Review.  25:170-182. 2020
  • Bioelectrical Impedance Analysis for the Assessment of Sarcopenia in Patients with Cancer: A Systematic Review..  25:170-182. 2020
  • What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision-Making in Patients and Oncologists.  24:1313-1321. 2019
  • Failure to Diagnose and Treat Hyperparathyroidism Among Patients with Hypercalcemia: Opportunities for Intervention at the Patient and Physician Level to Increase Surgical Referral.  24:e828-e834. 2019
  • Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis.  24:955-962. 2019
  • Barriers and Facilitators to Cervical Cancer Screening, Diagnosis, Follow-Up Care and Treatment: Perspectives of Human Immunodeficiency Virus-Positive Women and Health Care Practitioners in Tanzania.  24:69-75. 2019
  • Impact of Guideline-Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early-Stage Breast Cancer.  24:31-37. 2019
  • The Evolving Treatment Algorithm for Advanced Neuroendocrine Neoplasms: Diversity and Commonalities Across Tumor Types.  24:54-61. 2019
  • Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm.  23:1533-1545. 2018
  • The Role of Notch3 in Cancer.  23:900-911. 2018
  • Chemotherapy Toxicity Risk Score for Treatment Decisions in Older Adults with Advanced Solid Tumors.  23:573-579. 2018
  • Patient-Reported Comorbidity and Survival in Older Adults with Cancer.  23:433-439. 2018
  • Data linkage to improve geriatric oncology research: A feasibility study.  22:1002-1005. 2017
  • p16, HPV, and cetuximab: What is the evidence?.  22:811-822. 2017
  • Academic cancer center phase i program development.  22:369-374. 2017
  • Breast camps for awareness and early diagnosis of breast cancer in countries with limited resources: A multidisciplinary model from Kenya.  21:1138-1148. 2016
  • A phase II trial of a histone deacetylase inhibitor panobinostat in patients with low-grade neuroendocrine tumors.  21:785-786. 2016
  • Treatment summaries and follow-up care instructions for cancer survivors: Improving survivor self-efficacy and health care utilization.  21:817-824. 2016
  • The log odds of positive elymph nodes stratifies and predicts survival of high-risk individuals among stage III rectal cancer patients.  21:425-432. 2016
  • Occupational therapy for adults with cancer: Why it matters.  21:314-319. 2016
  • Geriatric assessment of older adults with cancer during unplanned hospitalizations: An opportunity in disguise.  20:767-772. 2015
  • BRCA1 and BRCA2 Mutations in Ethnic Lebanese Arab Women With High Hereditary Risk Breast Cancer.  20:357-364. 2015
  • Geriatric assessment-identified deficits in older cancer patients with normal performance status.  20:379-385. 2015
  • Identifying and addressing theneeds of adolescents and young adults with cancer: Summary of an institute of medicineworkshop.  20:186-195. 2015
  • Evaluation and management of the pediatric thyroid nodule.  20:19-27. 2015
  • Expanding cervical cancer screening and treatment in tanzania: Stakeholders’ perceptions of structural influences on scale-up.  20:621-626. 2015
  • Patterns of Storage, Use, and Disposal of Opioids Among Cancer Outpatients.  19:780-785. 2014
  • Hypothyroidism after a cancer diagnosis: Etiology, diagnosis, complications, and management.  19:34-43. 2014
  • Novel approaches in anaplastic thyroid cancer therapy.  19:1148-1155. 2014
  • Role of postoperative vitamindand/or calcium routine supplementation in preventing hypocalcemia after thyroidectomy:Asystematic review and meta-analysis.  18:533-542. 2013
  • Lymph node ratio predicts recurrence in papillary thyroid cancer.  18:157-162. 2013
  • Current understanding and management of medullary thyroid cancer.  18:1093-1100. 2013
  • Changes in swallowing-related quality of life after parathyroidectomy for hyperparathyroidism: A prospective cohort study.  17:1271-1276. 2012
  • What is the Utility of distal forearm DXA in primary Hyperparathyroidism?.  17:322-325. 2012
  • A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma.  16:835-843. 2011
  • A preclinical and clinical study of lithium in low-grade neuroendocrine tumors.  16:452-457. 2011
  • Perspectives and attitudes on the use of adjuvant chemotherapy and trastuzumab in older adults with HER-2+ breast cancer: A survey of oncologists.  14:883-890. 2009
  • Colonoscopic findings and tumor site do not predict bowel obstruction during medical treatment of stage IV colorectal cancer.  14:580-585. 2009
  • Carcinoid tumors.  13:1255-1269. 2008
  • Cancer survivorship: A pediatric perspective.  13:1181-1192. 2008
  • Pheochromocytoma: Current approaches and future directions.  13:779-793. 2008
  • Current management of medullary thyroid cancer.  13:539-547. 2008
  • Suberoyl bis-hydroxamic acid activates notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.  13:98-104. 2008
  • Renal cell carcinoma: New developments in molecular biology and potential for targeted therapies.  12:1404-1415. 2007
  • Tumor suppressor role of notch-1 signaling in neuroendocrine tumors.  12:535-542. 2007
  • Valproic acid activates Notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.  12:942-951. 2007
  • Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.  12:124-135. 2007
  • Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients.  11:336-341. 2006
  • Malignancy in neurofibromatosis type 1.  5:477-485. 2000
  • Thyroid abnormalities after therapy for hodgkin's disease in childhood.  1:62-67. 1996
  • International Standard Serial Number (issn)

  • 1083-7159
  • Electronic International Standard Serial Number (eissn)

  • 1549-490X